the french national alliance for life sciences and health aviesan prof. andré syrota chairman and...
Post on 10-Dec-2015
215 Views
Preview:
TRANSCRIPT
The French National Alliance for Life Sciences and Health
AVIESAN
Prof. André SyrotaChairman and CEO of InsermPresident of Aviesan
STOA, Brussels, June 2012
1
The scientific and political context
- Changes in the French research and higher education landscape. 2007: The autonomy of the universities. 2009: University Hospitals become research operators
. 2011: “Investments for the future” : 35 billion € (2.5 billion € for life and health sciences – equipments, cohorts, infrastructures, university hospital institutes, technological research institutes,…)
- The scientific challenges of the 21st century. Biology becoming « an integrative science » . New Health challenges: personalised medicine, ageing, emerging and reemerging diseases, health care systems,…
- A complex organisation in Health and Life sciences
4
Aviesan main objectives
• Scientific coordination • Strategic analysis • Scientific foresight• Programming (National and European levels)
• Operational coordination • Partnership with universities (funding, human resources)• Transfer of knowledge• Simplification
More visibility and reactivityTo share priorities on structuring projects
5
Aviesan10 multi-organization thematic institutes (Itmos)
Molecular and structural
bases of living organisms
Cell biology, development and evolution
Genetics, genomics and
bioinformatics
Immunology, hematology,
and pneumology
Microbiology and infectious
diseases
ANRS
Public health Health
Technologies
Cancer
INCa
Circulation,metabolism, and nutrition
6
Aviesan: Achievements
• Strategic analysis & scientific foresight
• Scientific animationAnnual conferences, thematic workshops and working groups (H1N1, Nutrition and Cancer, Vaccines, Radiobiology, Environment and Cancer, Epigenetics, Bioinformatics, rare diseases, etc)
• ProgrammingNational Research Agency (ANR), Thematic agencies within Aviesan Itmos, Investments for the future: research infrastructuresEuropean level: JPI, ESFRI BMS, FP7 Health priority, H 2020
• Structuring actionsH1N1, Research infrastructures, Environment and Health, Synthetic
Biology
• Partnership with Universities
• Transfer of knowledge
7
Aviesan: Transfer of Knowledge
- Annual meeting at the Governmental levelNeurosciences, Metabolism and Cardiovascular, Infectious diseasesR&D dating
- Sanofi Aventis-Aviesan agreementSponsorshipCollaboration agreementsJoint funding for project maturation
- Covalliance
- The epidemiologic portal
Strategic Council for health industry: Aviesan as the most appropriate partner
top related